Search

everythinglearnresearchcommunity

for

Search:↓

5α-reductase inhibitors can cause sexual problems, higher risk of aggressive prostate cancer, and depression.

Researchers found three patterns of Frontal fibrosing alopecia, with Pattern III having the best prognosis after treatment.

S5αR inhibitors might help treat schizophrenia and other mental disorders but need more research.

5-alpha reductase inhibitors can cause sexual side effects like erectile dysfunction and reduced sexual desire, sometimes lasting after stopping the drug.

Men taking 5α-reductase inhibitors for enlarged prostate have a higher chance of experiencing reduced sexual desire and erectile dysfunction.

Male pattern hair loss caused by follicular miniaturization; early diagnosis and treatment can reduce psychological burden.

5α-reductase inhibitors increase the risk of sexual dysfunction, especially in men with enlarged prostate.

Finasteride and minoxidil work best together for hair loss.

The document concludes that hair transplantation and gene therapy may be important for future hair loss treatment.

5α-reductase inhibitors and alpha-1 adrenergic antagonists together effectively treat benign prostatic hyperplasia, with long-term benefits.

As of December 2021, the most effective COVID-19 treatments were monoclonal antibodies and possibly early-administered convalescent plasma, while several drugs were found ineffective or were still under evaluation.

Certain drugs that block specific enzymes can help treat prostate diseases.

Non-binary transgender individuals need personalized hormonal treatments for better well-being and quality of life.

Hair loss treatments work better with lifestyle changes.

5-α-reductase inhibitors reduce prostate cancer risk but may cause sexual dysfunction and don't affect high-grade tumor or death rates.

FAGA diagnosis uses blood tests and trichoscopy, with treatments like topical minoxidil, oral anti-androgens, and hormone-modulating drugs.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Current treatments for male pattern baldness include minoxidil and finasteride, with new options being developed.

5-alpha reductase deficiency leads to male sexual development issues and treatments like finasteride help with prostate enlargement and hair loss.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

There are potential treatments for pattern baldness, but more research is needed to confirm their effectiveness.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

5-alpha reductase inhibitors slightly increase the risk of sexual and mood side effects, and breast growth in men.

Muscles can make their own androgens, which may help muscle growth.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Some hormone-related drugs may protect brain cells in Parkinson's disease differently in men and women.

Mesotherapy shows promise for cellulite and facial rejuvenation but has mixed results for body sculpting and hair loss, with more research needed for safety and effectiveness.

The document concludes that sexual and psychiatric side effects from 5-alpha-reductase inhibitors are reported, but more high-quality research is needed to understand how often they occur.

The document explains hair biology, the causes of hair loss, and reviews various hair loss treatments.

Finasteride shows promise for female hair loss, but more research needed.